Brokerages Set Chemed Corporation (NYSE:CHE) Price Target at $498.00

Shares of Chemed Corporation (NYSE:CHE) have been assigned a consensus recommendation of “Hold” from the six analysts that are currently covering the firm, MarketBeat reports. One analyst has rated the stock with a sell rating, three have assigned a hold rating and two have given a buy rating to the company. The average 1 year target price among brokers that have issued a report on the stock in the last year is $498.00.

Several equities analysts have weighed in on the company. Royal Bank Of Canada reaffirmed a “sector perform” rating and issued a $422.00 target price (down from $572.00) on shares of Chemed in a research report on Friday, February 27th. Weiss Ratings reissued a “hold (c-)” rating on shares of Chemed in a research note on Wednesday, January 21st. Zacks Research cut shares of Chemed from a “hold” rating to a “strong sell” rating in a report on Wednesday, March 4th. Jefferies Financial Group downgraded shares of Chemed from a “buy” rating to a “hold” rating in a research note on Thursday, January 22nd. Finally, Oppenheimer reduced their target price on shares of Chemed from $580.00 to $500.00 and set an “outperform” rating on the stock in a report on Friday, February 27th.

Chemed Stock Performance

NYSE:CHE opened at $368.42 on Friday. Chemed has a fifty-two week low of $365.20 and a fifty-two week high of $623.60. The company has a 50 day moving average price of $428.15 and a 200 day moving average price of $435.22. The stock has a market capitalization of $5.07 billion, a P/E ratio of 20.06, a PEG ratio of 1.46 and a beta of 0.47.

Chemed (NYSE:CHE) last released its quarterly earnings results on Wednesday, February 25th. The company reported $6.42 EPS for the quarter, missing the consensus estimate of $7.02 by ($0.60). The firm had revenue of $639.34 million for the quarter, compared to analysts’ expectations of $659.09 million. Chemed had a return on equity of 25.66% and a net margin of 10.48%.The company’s quarterly revenue was down .1% on a year-over-year basis. During the same quarter in the prior year, the business earned $6.83 earnings per share. Chemed has set its FY 2026 guidance at 23.250-24.250 EPS. Research analysts forecast that Chemed will post 21.43 earnings per share for the current fiscal year.

Chemed Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, March 13th. Stockholders of record on Monday, February 23rd were paid a $0.60 dividend. This represents a $2.40 annualized dividend and a dividend yield of 0.7%. The ex-dividend date was Monday, February 23rd. Chemed’s dividend payout ratio (DPR) is presently 13.06%.

Insider Transactions at Chemed

In related news, CEO Kevin J. Mcnamara sold 2,000 shares of the business’s stock in a transaction on Thursday, March 12th. The stock was sold at an average price of $403.18, for a total transaction of $806,360.00. Following the completion of the transaction, the chief executive officer directly owned 93,719 shares of the company’s stock, valued at $37,785,626.42. The trade was a 2.09% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Company insiders own 3.29% of the company’s stock.

Institutional Trading of Chemed

A number of large investors have recently made changes to their positions in CHE. Northwestern Mutual Wealth Management Co. boosted its position in shares of Chemed by 2,444,879.3% during the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 5,550,103 shares of the company’s stock worth $2,374,667,000 after acquiring an additional 5,549,876 shares in the last quarter. JPMorgan Chase & Co. raised its position in shares of Chemed by 4.4% during the 4th quarter. JPMorgan Chase & Co. now owns 521,900 shares of the company’s stock worth $223,301,000 after acquiring an additional 21,932 shares in the last quarter. William Blair Investment Management LLC lifted its stake in Chemed by 13.6% during the third quarter. William Blair Investment Management LLC now owns 385,124 shares of the company’s stock worth $172,435,000 after purchasing an additional 46,038 shares during the last quarter. AQR Capital Management LLC lifted its stake in Chemed by 89.2% during the fourth quarter. AQR Capital Management LLC now owns 325,579 shares of the company’s stock worth $139,302,000 after purchasing an additional 153,469 shares during the last quarter. Finally, TD Asset Management Inc boosted its holdings in Chemed by 7.5% in the fourth quarter. TD Asset Management Inc now owns 324,546 shares of the company’s stock valued at $138,860,000 after purchasing an additional 22,715 shares in the last quarter. 95.85% of the stock is currently owned by hedge funds and other institutional investors.

About Chemed

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.